Is It Too Late to Buy This Warren Buffett Stock That Has Soared in 2026?

Occidental reported strong fourth-quarter operating performance, including 1.481 million barrels of oil equivalent per day in Q4 and a new full-year production record of 1.434 million boe/d, while generating $4.3 billion in free cash flow before working capital. The company also benefited from higher crude prices, reduced debt to about $15 billion, and announced an 8% dividend increase after completing the $9.7 billion sale of OxyChem to Berkshire Hathaway. Despite the positive fundamentals, the article argues the stock has already rerated sharply, with a forward P/E of 12.5 versus a trailing P/E of about 42, limiting immediate upside.

Analysis

OXY’s setup is less about one quarter of strong execution and more about a structural de-risking of the equity story: a cleaner asset mix, lower leverage, and better capital return capacity. That combination usually rerates a cyclical producer from “balance-sheet repair” to “self-funding cash compounder,” but the market tends to pay up fastest right after the inflection, before commodity beta normalizes. The key second-order effect is that Berkshire’s large ownership reduces free float and can mute downside in the near term, but it also raises the odds that incremental marginal buyers are late-cycle momentum accounts rather than fundamental energy allocators.

The real variable is not production volume; it is whether the company can keep converting high prices into FCF if oil mean-reverts. At current valuation, the market is implicitly assuming a decent portion of today’s margin environment persists through the next 12 months, which is fragile if geopolitical risk premium fades or if global demand softens into a slower growth backdrop. The capex plan matters because it caps operating leverage on the upside: OXY can still grow cash flow, but after this move the equity likely has more sensitivity to commodity downside than to incremental operational upside.

Consensus may be underestimating how much of the recent rerating is already a monetization of improved balance-sheet optics rather than a durable step-change in intrinsic value. If crude stays elevated, the stock can keep grinding higher, but the better asymmetry now may sit in expressing a bullish energy view through higher-beta E&Ps or via options rather than owning a fully repriced large-cap. On the other hand, if oil rolls over even modestly, OXY’s multiple can compress quickly because the market has moved it from “distressed value” to “quality cyclical,” and quality cyclical names usually get punished hardest when the commodity tape turns.

Key Decisions for Investors

• Trim/avoid initiating a full-size long in OXY after the rerating; if entering, use a 3-6 month staggered buy only on a 5-8% pullback to improve entry on commodity mean-reversion risk.
• Prefer a bullish energy expression via a basket of higher-beta E&Ps (e.g., FANG, DVN, CTRA) over OXY for the next 2-4 quarters; OXY now looks more like a lower-upside cash compounder than the best torque to oil.
• For accounts that must own OXY, structure a call spread instead of stock ownership (3-6 month tenor) to capture residual upside while defining downside if Brent/WTI retraces and the multiple compresses.
• Pair trade: long a diversified energy basket / short OXY on a 6-12 month horizon if you expect the market to rotate from balance-sheet story to pure commodity beta; OXY’s de-levered story leaves less incremental rerating room than peers still showing operating leverage.
• Set a risk trigger: if WTI falls back below the low-$80s, reduce OXY exposure aggressively; the equity’s post-runup valuation leaves limited cushion against a 10-15% move in crude.